Leap Therapeutics, Inc.
LPTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $27 | $18 | $33 | $47 |
| Short-Term Investments | $147 | $0 | $0 | $0 |
| Receivables | $0 | $1 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $0 | $0 | $0 |
| Total Curr. Assets | $179 | $19 | $34 | $48 |
| Property Plant & Equip (Net) | $66 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $50 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $1 | $1 |
| Total NC Assets | $116 | $1 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $295 | $20 | $35 | $49 |
| Liabilities | – | – | – | – |
| Payables | $13 | $7 | $6 | $5 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $7 | $7 | $9 |
| Total Curr. Liab. | $21 | $14 | $14 | $14 |
| LT Debt | $3 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $29 | $0 | $0 | $0 |
| Total NC Liab. | $32 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $0 | $0 | $0 |
| Total Liabilities | $53 | $14 | $14 | $14 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$297 | -$499 | -$483 | -$467 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $539 | $505 | $504 | $503 |
| Total Equity | $242 | $6 | $21 | $35 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $295 | $20 | $35 | $49 |
| Net Debt | -$23 | -$18 | -$33 | -$47 |